2020
DOI: 10.1016/j.rmcr.2020.101214
|View full text |Cite
|
Sign up to set email alerts
|

A case series of coinfection with SARS-CoV-2 and influenza virus in Louisiana

Abstract: Severe acute respiratory syndrome coronavirus–2 (SARS-CoV-2) is the novel coronavirus initially detected in Wuhan, China, and is responsible for the worldwide pandemic coronavirus disease 2019 (Covid-19). Influenza is a common endemic respiratory virus that causes seasonal outbreaks of respiratory illness. There are currently few reports in the literature describing patients with coexisting infections. This case series of 4 patients identified at our single institution in Louisiana highlights the patient chara… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
21
0
1

Year Published

2020
2020
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 22 publications
(22 citation statements)
references
References 12 publications
0
21
0
1
Order By: Relevance
“…Another two case series in which almost all patients had a medical history of hypertension, and a significant proportion of them were diabetic or on hemodialysis, were published. Although almost all patients were classified as being part of high-risk categories, their clinical evolution did not differ from previously reported monoinfections with SARS-CoV-2 [ 32 , 33 ]. However, severe or fatal COVID-19 outcomes have also been described in isolated case reports of coinfections with influenza [ 34 ] or other viral, bacterial [ 35 ], or fungal pathogens (especially Aspergillus fumigatus) [ 36 ].…”
Section: Is One Plus One Equal To Two? the Clinical Outcomes Of Pamentioning
confidence: 72%
“…Another two case series in which almost all patients had a medical history of hypertension, and a significant proportion of them were diabetic or on hemodialysis, were published. Although almost all patients were classified as being part of high-risk categories, their clinical evolution did not differ from previously reported monoinfections with SARS-CoV-2 [ 32 , 33 ]. However, severe or fatal COVID-19 outcomes have also been described in isolated case reports of coinfections with influenza [ 34 ] or other viral, bacterial [ 35 ], or fungal pathogens (especially Aspergillus fumigatus) [ 36 ].…”
Section: Is One Plus One Equal To Two? the Clinical Outcomes Of Pamentioning
confidence: 72%
“…Several reports of co-infection with influenza were obtained after the first wave of COVID-19 in early 2020 [ 19 , 40 – 46 ]. Four reports from China detailed a high frequency of influenza co-infection, especially for influenza A variants [ 19 , 42 , 43 , 46 ].…”
Section: The Covid-19 Experiencementioning
confidence: 99%
“…Coinfection or sequential infection was associated with an accentuation of lung pathology. Several reports of co-infection with influenza were obtained after the first wave of COVID-19 in early 2020 [19,[40][41][42][43][44][45][46]. Four reports from China detailed a high frequency of influenza co-infection, especially for influenza A variants [19,42,43,46].…”
Section: Co-detection Of Sars-cov-2 and Influenza Virusmentioning
confidence: 99%
“…The continuation of antimicrobial treatment and duration of hospital stay of COVID-19 patients can be shortened substantially with stewardship measures. Antimicrobial governance initiatives should actively involve and train medical practitioners and pharmacists to reduce mishandling of antibiotics during the COVID-19 pandemic [ 88 , 89 ]. The recommendations made in this study and their efficient inclusions in the formation of applicable policies and the preparation of concrete instructions/guidelines will be crucial to ensure our battle against AMR continues and the quest to conquer it consummates.…”
Section: Tackling Measuresmentioning
confidence: 99%